Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Newspaper publisher Johnston Press puts itself up for sale

The company behind the ‘i’ newspaper and The Scotsman has decided that putting itself up for sale is the only option after failing to find a way to restructure its hefty debts
i newspaper
In 2005, Johnston Press was valued at £1.6bn

UK newspaper publisher Johnston Press PLC (LON:JPR) has put itself up for sale after exhausting all other options to restructure or refinance its hefty debts.

The company, which has a market cap of less than £5mln, had been exploring ways to refinance its £220mln bond debts when they mature next June.

READ: Johnston Press explores debt restructuring options

Credit agencies had previously said that this would be nigh-on impossible and Johnston has now conceded that putting itself up for sale is the only option.

The firm has seen the value of its titles, which include the ‘i’, The Scotsman and the Yorkshire Post, tumble in recent years following a decline in traditional and digital advertising revenues.

In its latest results, Johnston Press reported a 10% fall in revenues during the first half of 2018.

It swung back to a profit of £6.2mln for the six-month period, but this was almost entirely due to a one-off accounting gain of £8.8mln.

Custos Group, headed up by Norwegian entrepreneur Christen Ager-Hanssen, has a 20% stake in Johnston and has been linked with a potential bid approach in the past.

US hedge funds were also said to be positioning themselves for a takeover last year after snapping up the company’s bonds at a discount.

Despite the rumoured interest, Johnston confirmed it is not in discussions with any potential suitors at the moment.

Shares rose 4.8% to 3.4p on Thursday morning.

View full JPR profile View Profile

Johnston Press plc Timeline

Related Articles

Throne of Glass
April 30 2018
Rowling, Rowling, Rowling ... keep those titles rolling. Mind you, it's not all about Ms Rowling; Sarah J Maas title revenues grew 47% in the first half of the financial year and dieters are gorging on Tom Kerridge's books
ipad
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”
Lego ball
September 14 2018
The company's latest push is a joint venture agreement with US-based entertainment firm Three Six Zero, which has steered the careers of pop stars such as Calvin Harris

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use